Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: A phase I/II trial

Journal of Clinical Oncology

Volumn 16, Issue 4, 1998, Pages 1331-1339

  Colevas, A Dimitrios ^a   Busse, Paul M ^a   Norris, Charles M ^a   Fried, Marvin ^a   Tishler, Roy B ^a   Poulin, Mark ^a   Fabian, Richard L ^a   Fitzgerald, T J ^a   Dreyfuss, A ^a   Peters, Edward S ^a   Adak, Sudeshna ^a   Costello, Rosemary ^a   Barton, Jennifer J ^a   Posner, Marshall R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; EDEMA; FATIGUE; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; NEUROTOXICITY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0031925302     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.4.1331     Document Type: Article

References (39)

1. Lefebvre J, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88:890-898, 1996
2. Veterans Affairs Laryngeal Cancer Study Group V: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1689, 1991
3. Jacobs C: Head and neck cancer in 1994: A change in the standard of care. J Natl Cancer Inst 86:250-252, 1994
4. Merlano M, Benasso M, Corvo R, et al: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589, 1996
5. Paccagnella A, Orlando A, Marchiori C, et al: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del collo. J Natl Cancer Inst 86:265-272, 1994
6. Spaulding M, Fischer S, Wolf G: Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 12:1592-1599, 1994
7. Kish J, Weaver A, Jacobs J, et al: Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53:1819-1824, 1984
8. Kish J, Ensley J, Jacobs J, et al: A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56:2740-2744, 1985
9. Vokes E, Weichselbaum R, Mick R, et al: Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 84:877-882, 1992
10. Ang K, Peters L: Altered fractionation in radiation oncology. PPO Updates 8:1-15, 1994
11. Bachaud J, David J, Boussin G, et al: Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: Preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 20:243-246, 1991
12. Eisbruch A, Thorton A, Urba S, et al: Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer. J Clin Oncol 14:2322-2330, 1996
13. Fu K, Clery M, Ang K, et al: Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: Results of RTOG 88-098. Int J Radiat Oncol Biol Phys 32:589-597, 1995
14. Lusinchi A, Lartigau E, Luboinski B, et al: Accelerated radiation therapy in the treatment of very advanced and inoperable head and neck cancers. Int J Rad Oncol Biol Phys 29:149-152, 1994
15. Brizel D, Albers M, Fisher S, et al: A phase III trial of hyperfractionated irradiation ± concurrent chemotherapy for locally advanced carcinoma of the head and neck: Superiority of combined modality treatment. Proc Am Soc Clin Oncol 16:1368, 1997 (Abstr)
16. Belliveau J, Posner M, Cummings F, et al: Clinical and pharmacokinetic study of cis-diammine dichloroplatinum (II) administered as a continuous infusion. Cancer Treat Rep 70:1215-1227, 1986
17. Forastiere A, Belliveau J, Goren M, et al: A pharmacokinetic and toxicity evaluation of 5-day continuous infusion versus intermitent bolus cisplatin in head and neck cancer patients. Cancer Res 48:3869-3874, 1988
18. Posner M, Skarin A, Clark J, et al: Phase I study of continuous-infusion cisplatin. Cancer Treat Rep 70:847-850, 1986
19. Clark J, Busse P, Norris C, et al: Induction chemotherapy with cisplatin, flourouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: Long-term results. J Clin Oncol 15:3100-3110, 1997
20. Vokes E, Schilsky R, Weichselbaum R, et al: Induction chemotherapy with cisplatin, fluorouracil and high-dose leucovorin for locally advanced head and neck cancer: A clinical and pharmacologic analysis. J Clin Oncol 8:241-247, 1990
21. Schneider M, Etienne M, Milano G, et al: Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: A pharmacokinetic and clinical survey. J Clin Oncology 13:1656-1662, 1995
22. Dreyfuss A, Clark J, Norris C, et al: Docetaxel: An active drug for squamous cell carcinoma of the head and neck. J Clin Oncol 14:1672-1678, 1996
23. Forastiere A, Neuberg D, Leong T, et al: Eastern Cooperative Group (ECOG) paclitaxel studies in advanced head and neck cancer. Head Neck 16:481, 1994 (abstr 35)
24. Forastiere A, Neuberg D, Taylor S, et al: Phase II evaluation of taxol in advanced head and neck cancer: An Eastern Cooperative Oncology Group trial. Monogr Natl Cancer Inst 15:181-184, 1993
25. Catimel G, Verwij J, Hanauske A: Docetaxel (Taxotere): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. Ann Oncol 5:553-537, 1994
26. Couteau C, Leyvraz S, Oulid-Aissa D, et al: A phase II study of docetaxel in squamous cell carcinoma (SCC) of the head and neck. Proc Am Soc Clin Oncol 15:315, 1996 (Abstr)
27. Fujii H, Sasaki Y, Ebihara S, et al: An early phase II study of docetaxel (Taxotere) in patients with head and neck cancer. Proc Am Soc Clin Oncol 14:298, 1995 (Abstr 859)
28. Rowinsky E: The taxanes: dosing and scheduling considerations. Oncology 11:7-18, 1997
29. Munro A: An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71:83-91, 1995
30. El-Sayed S, Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials. J Clin One 14:838-847, 1996
31. Merlano M, Vitale V, Rosso R, et al: Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327:1115-1121, 1992
32. Merlano M, Rosso R, Sertoli R, et al: Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: A Phase III Study. J Clin Onc 6:627-632, 1988
33. Taylor S, Murthy A, Vannetzel J, et al: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12:385-395, 1994
34. (SECOGI) S-EC-oOG: A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 12:289-295, 1986
35. Adelstein D, Sharan V, Earle A, et al: Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 65:1685-1691, 1990
36. Tishler R, Geard C, Hall E, et al: Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 52:3495-3497, 1992
37. Tishler R, Schiff P, Geard C, et al: Taxol: A novel radiation sensitizer. Int J Radiat Oncol Biol Phys 22:613-617, 1992
38. Diaz J, Andreu J: Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere. Biochemistry 32:2747-2755, 1993
39. Haldar S, Basu A, Croce C: Bcl2 is the guardian of microtubule integrity. Cancer Res 57:229-233, 1997